URGENT NOTIFICATION FROM PRIME THERAPEUTICS   July  13, 2016 Dear Valued Provider, We are currently experiencing unexpected system downtime, which is affecting claims processing. We apologized for any inconvenience, we will communicate when the system is available for claims processing. If you have any questions regarding processing claims, please call the Prime Contact Center at 800.821.4795. Thank you, Pharmacy Network Management Prime Therapeutics LLC

RXBIN: 004336 RXPCN: MCAIDOH RXGRP: RX6407 Effective August 2, 2016, ProAir HFA will no longer be preferred on the Paramount Advantage™ Healthcare formulary. Ventolin HFA will be the preferred exclusive short-acting beta agonist inhaler. All other albuterol HFA agents will require prior authorization.

Community Care Alliance of Illinois and Family Health Network are existing plan sponsors with CVS/caremark. Effective July 15, 2016, CCAI and FHN will make the following formulary changes.

We are writing to inform you that HealthPartners is limiting coverage for several non-FDA-approved products starting on October 1, 2016.These limited products include:• EnovaRx - Amitryptyline cream• Tri-Chlor (trichloroacetic acid) 80% solution• L-glutamine powder• Salicylic acid powder

FutureScripts® will manage claims processing for members of AmeriHealth Administrators, Independence Administrators and Inter-County Health Plan